AzTrials
AzTrials

SmokingNCT02866760

Helping In-patients to Quit Smoking by Understanding Their Risk Perception, Behavior, and Attitudes Related to Smoking

An observational study of Smoking, run by The University of Hong Kong at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims at understanding the needs and concerns of Chinese current smoking patients, including their risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Smoking
How many people
412 participants
Where
1 siteChina
Study dates
Jul 2016to 29 Aug 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Phase 1 Qualitative study: Chinese patients admitting to either medical or surgical units of one of the largest acute hospital in Hong Kong for physical discomfort. Phase 2 Survey study: Chinese patients attending one of the three general outpatient clinics at different regions in Hong Kong for medical follow-up.

Who may be able to join

  • aged 18 years or above
  • able to speak Cantonese Phase 1:(3) current smokers, either occasional or daily(4) hospitalized for at least 48 hours Phase 2:(3) current smokers who have resumed smoking or ex-smokers who have quitted smoking after hospitalization(4) admitted to hospitals, either medical or surgical units during the past 3 months.

Who cannot join

  • unstable medical conditions, as advised by the doctor in charge
  • poor cognitive state or active psychotic symptoms

Trial locations and contacts

1 site in 1 country.

China1 site
  • The University of Hong Kong

    Hong Kong

Other trials in China

About this study

This study aims at understanding the needs and concerns of Chinese current smoking patients, including their risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation. Specifically, how smokers overcome withdrawal symptoms and cigarette cravings, as a result of banning on smoking in hospitals, will be explored. In addition, whether smokers will stop, resume or continue smoking after hospitalization will be investigated.

Read the detailed description

As about 400,000 hospitalizations are attributable to smoking annually in Hong Kong, it is an excellent "teachable moment" for healthcare professionals to help patients quit smoking. To our knowledge, this is the first study to investigate the needs and concerns of Chinese current smoking patients, including their risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation. The findings of this study have important implications for research and clinical practice.

Understanding how hospitalized smokers perceive the risks of smoking, and their behaviour, attitudes, experiences related to smoking, as well as their view on hospital smoking cessation service are essential prerequisites for the design of an effective and appropriate smoking cessation intervention that can help patients achieve a greater level of smoking abstinence and a lower level of relapse. Moreover, the results of this study can guide the development of protocols and interventions that will demystify the misconceptions about smoking among hospitalized smokers, increase their perception of the risks of continued smoking and benefits of quitting. Additionally, it is crucial to motivate more healthcare professionals to assess health behaviors of hospitalized smokers and to implement evidence-based interventions to help them quit smoking. Most importantly, healthcare professionals should be offered relevant training so as to enhance their self-efficacy and confidence in promoting smoking cessation to patients.

The study consists of 2 phases. During phase 1, a purposive sample of 30 current adult smokers who admit to either medical or surgical units of one of the largest cute hospitals in Hong Kong will be invited to have a 60-minute semi-structured interview. The risk perceptions, and the behaviour, attitudes, and experiences related to smoking and smoking cessation amongst Chinese current smoking patients will be explored. Concerning phase 2, a convenience sample of 382 adult patients who are current smokers or ex-smokers in the three out-patient clinics will be invited to response to the questionnaires. Based on the findings of Phase 1 study, a survey study will be conducted to further explore the behaviour, attitudes, and experiences related to smoking and smoking cessation amongst those patient who smoked before their admission to hospitals.

Conditions
Smoking
Keywords
Smoking Cessation
Medical subject headings
Smoking, Smoking Cessation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The behavior, attitudes, and experiences related to smoking and smoking cessation among Chinese current smoking patients

    1. smoking patients' risk perceptions, and the behavior, attitudes, and experiences related to smoking and smoking cessation
    2. how they overcome withdrawal symptoms and cigarette cravings, as well as their view on hospital smoking cessation service

    Measured: 3 months

Secondary outcomes (1)
  1. The behavior, attitudes, and experiences related to smoking and smoking cessation among those patients who smoked before their admission to hospitals

    whether they (1) experience withdrawal symptoms or cigarette cravings and depressive symptoms during and after hospitalization (2)receive medical advice for quitting during hospitalization (3) have stopped, resumed or continued smoking after hospitalization (4) have intention to quit (5) have an increase in the risk perception toward smoking.

    Measured: 10 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2016 (estimated)
  2. Study startJul 2016
  3. Primary completion29 Aug 2017
  4. Study completion29 Aug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
412 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02866760
Sponsor's protocol ID
In-patient
Status last verified
Jul 2018
First submitted
4 Aug 2016
Last updated
13 Jul 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Ho KY, Li WHC, Lam KKW, Wang MP, Xia W, Ho LY, Tan KCB, Sin HKM, Cheung E, Mok MPH, Lam TH. Smoking behaviours of Hong Kong Chinese hospitalised patients and predictors of smoking abstinence after discharge: a cross-sectional study. BMJ Open. 2018 Dec 19;8(12):e023965. doi: 10.1136/bmjopen-2018-023965.

    PubMed 30573486

Questions about this trial

What is this clinical trial studying?

An observational study of Smoking, run by The University of Hong Kong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The behavior, attitudes, and experiences related to smoking and smoking cessation among Chinese current smoking patients (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02866760, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in